This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
iRobot (IRBT) Beats on Q2 Earnings, Hikes View for 2020
by Zacks Equity Research
iRobot's (IRBT) second-quarter 2020 earnings gain from solid demand for Roomba and Braava products, expense management, and tariff exclusion. Sales prospects are anticipated to improve in 2020.
Reasons Why Avoiding Barnes' (B) Stock is Preferable Now
by Zacks Equity Research
Barnes' (B) Industrial and Aerospace segments suffer from the pandemic-related restrictions and uncertainties. It expects organic sales to have declined in second-quarter 2020.
Analysts Estimate Idex (IEX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PH or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
PH or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
PH vs. IEX: Which Stock Is the Better Value Option?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?
by Zacks Equity Research
Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns. However, cost-reduction actions might aid.
Idex (IEX) Down 1.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kennametal's (KMT) Near-Term Prospects Bleak on Pandemic Woes
by Zacks Equity Research
Kennametal (KMT) will likely continue suffering from the operational and end-market uncertainties caused by the pandemic. Forex woes and restructuring charges are other concerns.
IDEX (IEX) Q1 Earnings & Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
IDEX's (IEX) first-quarter 2020 revenues decline 4.5% year over year on account of lackluster performance across all of its segments.
Idex (IEX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 3.10% and 0.08%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investors Should Ignore Flowserve (FLS) for Now
by Zacks Equity Research
Flowserve's (FLS) operations are exposed to uncertainties caused by the coronavirus outbreak. Also, high debts, realignment expenses and forex woes might be concerning.
Earnings Preview: Idex (IEX) Q1 Earnings Expected to Decline
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TNC vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TNC vs. IEX: Which Stock Is the Better Value Option?
Drab Near-Term Prospects for Industrial Manufacturing Stocks
by Avisekh Bhattacharjee
The Manufacturing - General Industrial industry is facing coronavirus-related issues, job losses & other problems. Technological advancement in manufacturing processes will likely be a growth driver.
Here's Why You Should Avoid Betting on IDEX (IEX) Stock Now
by Zacks Equity Research
IDEX (IEX) has been suffering from difficult end-market conditions and several other issues.
TNC vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TNC vs. IEX: Which Stock Is the Better Value Option?
IDEX (IEX) Authorizes Share Repurchase Program Worth $500M
by Zacks Equity Research
IDEX's (IEX) approval of an additional share repurchase program worth $500 million is likely to instill confidence among investors.
FERGY vs. IEX: Which Stock Is the Better Value Option?
by Zacks Equity Research
FERGY vs. IEX: Which Stock Is the Better Value Option?
Kennametal (KMT) Declines 39% YTD: What's Hurting the Stock?
by Zacks Equity Research
Kennametal (KMT), with a 39% decline in shares so far in 2020, faces headwinds from difficult end-market conditions, issues with 737 MAX and higher taxes.
Altra Industrial (AIMC) Declines 40% YTD: What's Hurting it?
by Zacks Equity Research
Altra Industrial (AIMC), with shares down 40% so far in 2020, faces headwinds from difficult end-market conditions, unfavorable movements in foreign currencies and the coronavirus outbreak.
IDEX's (IEX) Flow Management Buyout to Boost Energy Business
by Zacks Equity Research
IDEX's (IEX) buyout of Flow Management Devices is likely to boost the energy business, especially from pipeline operators, refineries and chemical manufacturers.
Idex (IEX) Down 8.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Reasons Why You Should Avoid IDEX (IEX) Stock for Now
by Zacks Equity Research
IDEX (IEX) is exposed to challenging end markets, unfavorable movements in foreign currencies, and the impacts of variable compensation, tax rate and growth investments.
New Strong Sell Stocks for February 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today